The Effect of Sleep Caps on Sleep and Physiological Parameters in Infants in the Neonatal Intensive Care Unit

by palligoelme@gmail.com | Feb 20, 2026 | Clinical Trials

​ Conditions: Newborn; Neonatal Intensive Care Unit; Neonatal Intensive Care; Sleep; Physiological Parameters; Nursing Care; Neonatal Care Interventions: Other: Experiment group Sponsors: Aydin Adnan Menderes University Completed Conditions: Newborn; Neonatal...

Real-world Canadian Retrospective Study Evaluating Longitudinal Semaglutide Use on Cardio-Kidney-Metabolic Outcomes

by palligoelme@gmail.com | Feb 20, 2026 | Clinical Trials

​ Conditions: Diabetes (DM); Type 2 Diabetes; Obesity (Disorder) Interventions: Drug: Semaglutide (SEMA) Sponsors: LMC Diabetes & Endocrinology Ltd. Not yet recruiting Conditions: Diabetes (DM); Type 2 Diabetes; Obesity (Disorder) Interventions: Drug: Semaglutide...

Study to Investigate Vagus Nerve Stimulation to Augment Executive Function in Healthy and Cognitively Impaired Populations

by palligoelme@gmail.com | Feb 20, 2026 | Clinical Trials

​ Conditions: Mild Cognitive Impairment (MCI); Parkinsons Disease (PD); Healthy Adult Interventions: Device: transcutaneous auricular vagus nerve stimulation; Device: sham stimulation Sponsors: University of Colorado, Denver Recruiting Conditions: Mild Cognitive...

Impact of Therapeutic Storytelling on Fear, Screen Time, and Parental Stress Among Hospitalized Children

by palligoelme@gmail.com | Feb 20, 2026 | Clinical Trials

​ Conditions: Hospitalized Children; Parent Stress Interventions: Behavioral: Therapeutic Story Telling; Other: routine care Sponsors: Karabuk University Completed Conditions: Hospitalized Children; Parent Stress Interventions: Behavioral: Therapeutic Story Telling;...

Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose

by palligoelme@gmail.com | Feb 20, 2026 | Clinical Trials

​ Conditions: Healthy Participants; Pharmacokinetics Interventions: Drug: Evolocumab Drug Substance A; Drug: Evolocumab Drug Substance B Sponsors: Amgen Recruiting Conditions: Healthy Participants; Pharmacokinetics Interventions: Drug: Evolocumab Drug Substance A;...